Launches first-of-its-kind automated ultrasound platform to accelerate preclinical research WALTHAM, Mass. –(BUSINESS WIRE)–Apr. 7, 2022– PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced the expansion of its in vivo imaging portfolio

Original Source

Notice: ob_end_flush(): failed to send buffer of zlib output compression (0) in /home/biznews/public_html/wp-includes/functions.php on line 5219